MEMPHIS, Tenn., Sept. 25, 2019 /PRNewswire/ -- St. Jude Children's Research Hospital® patient Gabe recently took his first steps sin

NEW YORK, Sept. 25, 2019 /PRNewswire/ -- United Spinal Association played a key role in championing a resolution that passed the U.S. Senate designating S

CHARLOTTE, N.C., Sept. 25, 2019 /PRNewswire/ -- cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), has signed a comprehensive, multi-year Partnership agreement with Life Time to bring CBD awareness and education to millions of Americans coast-to-coast. Founded in 1992, Life Time develops and operates compr

ABBOTT PARK, Ill., Sept. 25, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its ARCHITECT STAT High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug Administration (FDA). As one of the most researched troponin diagnostic tests, doctors in the U.S. can now utilize this proven technology to help detect heart attacks faster and more accurately than con

PORTLAND, Ore., Sept. 25, 2019 /PRNewswire/ -- The CHP Group (CHP), the recognized leader and partner of choice in integrative healthcare, announces the release of the 2018 Patient Satisfaction Survey results. This survey – in its 18th year – is of seminal importance in understanding patient use, attitudes, and outcomes regarding integrative health

SAN FRANCISCO and HERZLIYA, Israel, Sept. 25, 2019 /PRNewswire/ -- 89bio, Inc. (89bio or the company), a clinical-stage biopharmaceutical company, has initiated dosing in its proof of concept Phase 1b/2a clinical trial evaluating its product candidate, BIO89-100, in patients with nonalcoholic steatohepat

PHILADELPHIA, Sept. 25, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) ("Lannett" or the "Company") today announced the pricing of $75 million aggregate principal amount of 4.50% convertible senior notes due 2026 (the "Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act

SAN FRANCISCO, Sept. 25, 2019 /PRNewswire/ -- JUUL Labs announced today that K.C. Crosthwaite will be joining the company as CEO effective immediately. The announcement from co-founders James Monsees, Adam Bowen and Kevin Burns follows Burns' decision to step down. In

CHARLOTTESVILLE, Va., Sept. 25, 2019 /PRNewswire/ -- HemoShear Therapeutics, LLC, a privately held biotechnology company focused on discovering and developing drugs for metabolic disorders, has appointed Brian A. Johns, PhD, as Chief Scientific Officer. Dr. Johns joins the company following a prolific 20-year career with GSK, where he

LOS ANGELES, Sept. 25, 2019 /PRNewswire/ -- ImaginAb Inc., a clinical-stage immuno-oncology imaging company, today announces it has enrolled its first patient for the Phase II clinical trial of its lead product CD8 tracer, 89Zr-Df-IAB22M2C, at the O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UA